AMYNDAS PHARMACEUTICALS S.A.
Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the complement system.
AMYNDAS PHARMACEUTICALS S.A.
Social Links:
Industry:
Biotechnology Pharmaceutical
Address:
Philadelphia, Pennsylvania, United States
Country:
United States
Website Url:
http://www.amyndas.com
Total Employee:
1+
Status:
Active
Contact:
+1 (484) 620-3236
Email Addresses:
[email protected]
Technology used in webpage:
Euro Cloudflare Hosting Google Google Cloud COVID-19
Similar Organizations
Akroswiss
Pharmaceutical company
Alembic Pharmaceuticals
Alembic is a pharmaceutical company.
Amplity
Amplity is a pureplay pharmaceutical commercialization service organization.
Angiotech Pharmaceuticals
Angiotech is a Vancouver, British Columbia pharmaceutical company.
Aurobindo Pharma USA, Inc.
Aurobindo Pharma is a pharmaceuticals company offering generic pharmaceuticals.
BRIM Biotechnology
BRIM Biotechnology is a pharmaceutical company.
Enzyme BioSystems
Enzyme BioSystems is a Pharmaceuticals Company.
Neuraxpharm
Neuraxpharm is a Pharmaceutical Company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
SERB
Brussels-based specialty pharma company.
Current Employees Featured
Founder
Official Site Inspections
http://www.amyndas.com
- Host name: 169.142.69.34.bc.googleusercontent.com
- IP address: 34.69.142.169
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Amyndas Pharmaceuticals S.A."
Home – Amyndas Pharmaceuticals
Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the …See details»
Management – Amyndas Pharmaceuticals
Konstantinos Georgiou, member of the Amyndas BoD. General Manager of Human Resources Administration & Logistics and member of the BoD for Geniki Bank as well as other …See details»
Amyndas Pharmaceuticals S.A. - Crunchbase
Organization. Amyndas Pharmaceuticals S.A. Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Amyndas is a pharmaceutical company developing potent complement …See details»
Our Focus - Amyndas Pharmaceuticals
AMYNDAS’ PRIORITY CLINICAL PROGRAMS. ... Cancer Immunotherapy: According to the World Health Organization, cancer is among the leading causes of death worldwide. In 2012, …See details»
Amyndas Pharmaceuticals Initiates Phase 2a study of AMY-101 in …
Aug 28, 2019 For additional information about AMY-101 and Amyndas Pharmaceuticals, please visit www.amyndas.com. About the Forsyth Institute. Founded in 1910, the Forsyth Institute is …See details»
Amyndas Pharmaceuticals S.A. - Contacts, Employees, Board …
Amyndas Pharmaceuticals S.A. has 2 current employee profiles, including Managing Director Despina Yancopoulou. Despina Yancopoulou Managing Director John Lambris FounderSee details»
Amyndas Pharmaceuticals - Products, Competitors, Financials, …
Amyndas Pharmaceuticals is a pharmaceutical company focused on developing complement therapeutics for inflammatory diseases and disorders. Use the CB Insights Platform to explore …See details»
Amyndas Pharmaceuticals - VentureRadar
Amyndas is a pharmaceutical company developing potent complement therapeutics for inflammatory diseases and disorders based on its patented technology for modulating the …See details»
Amyndas Pharmaceuticals - Philadelphia, Pennsylvania, United …
Amyndas is a fast-developing innovator and emerging leader in the field of “complement therapeutics”, with a compelling investment proposition, a highly promising pipeline and …See details»
Amyndas Announces Positive Top-Line Phase 2 Results for …
Mar 19, 2021 Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel complement therapeutics, announced today posit ... Forsyth is a …See details»
What We Do – Amyndas Pharmaceuticals
Amyndas is a fast-developing innovator and emerging leader in the field of “complement therapeutics,” with a compelling investment proposition, a highly promising pipeline and …See details»
FDA grants orphan drug designation for PNH to Amyndas …
Oct 12, 2014 Amyndas is planning to move AMY-101 into the clinic for first-in-human trials in 2015, and the Orphan Drug Designation should prove valuable in the clinical development of …See details»
Amyndas : Announces Positive Top-Line Phase 2 Results for ...
Mar 19, 2021 Amyndas Pharmaceuticals, a clinical-stage biopharmaceutical company focused on the development of novel complement therapeutics, ... Founded in 1910, the Forsyth …See details»
Amyndas’ lead candidate AMY-101 receives orphan drug status …
Feb 29, 2016 Amyndas Pharmaceuticals SA, which is committed to developing innovative therapeutics to treat complement-mediated disorders, announced today that its lead …See details»
The Aplastic Anemia & MDS International Foundation supports …
Sep 21, 2015 Amyndas Pharmaceuticals S.A. is pleased to announce today that the Aplastic Anemia & MDS International Foundation (AA&MDSIF) is endorsing the clinical development of …See details»
John D. Lambris, Ph.D. – Amyndas Pharmaceuticals
Read more about Amyndas' founder, Dr. John D. Lambris. Dr. Lambris, the Dr. Ralph and Sallie Weaver Professor of Research Medicine in the Department of Pathology & Laboratory …See details»
Amyndas Pharmaceuticals LLC (Amyndas Pharmaceuticals LLC)
了解Amyndas Pharmaceuticals LLC (Amyndas Pharmaceuticals LLC)公司的药物管线，治疗领域，技术平台，以及它的4项临床试验, 7篇新闻和16篇文献，疾病领域:免疫系统疾病，技术平 …See details»
Compstatin 40 - Drug Targets, Indications, Patents - Synapse
Amyndas has a robust R&D complement program with the strongest and most diversified pipeline of C3 complement inhibitors in the field. For additional information please visit . About the …See details»
Quartesian Announces Amyndas Partnership for COVID-19 Clinical …
PRINCETON, N.J., June 16, 2020 /PRNewswire/ — Quartesian, a multinational Clinical Research Organization (CRO) serving the biopharmaceutical and medical device industries, today …See details»
Our Pipeline – Amyndas Pharmaceuticals
Learn more about Amyndas' pipeline. Our Pipeline. Amyndas is developing the next generation Compstatins, compounds targeting complement inhibition on cell surfaces by Compsorbin, and …See details»